Search for: "Boehringer Ingelheim Pharmaceuticals" Results 1 - 20 of 250
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2020, 9:57 pm by Patent Docs
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
10 Aug 2016, 1:27 pm by Naumes Law
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
20 Nov 2012, 8:32 am by fraudfighters
  This settlement was with pharmaceutical giant Boehrigner Ingelheim Pharmaceuticals Inc. [read post]
19 Apr 2013, 1:12 pm by Nazareth M. Haysbert
The spouse of a deceased Pradaxa user has filed a wrongful death lawsuit against the drug’s manufacturer Boehringer Ingelheim Pharmaceuticals, claiming her husband experienced a brain hemorrhage after using Pradaxa, resulting in his death. [read post]
22 Mar 2018, 6:11 am by Robert Kraft
Reuters reports, “Boehringer Ingelheim will pay $13.5 million to” settle claims from all 50 state attorneys general “that the pharmaceutical company used deceptive and misleading marketing to promote” four drugs “for unapproved purposes. [read post]
10 Aug 2016, 1:27 pm by Naumes Law
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
28 Oct 2012, 6:37 pm
Boehringer Ingelheim Pharmaceuticals Inc., a Germany-based pharmaceutical company that markets and sells drugs in the United States, has recently agreed to settle claims that it illegally promoted four of its best-selling drugs for $95 million. [read post]
8 May 2016, 9:59 pm by Patent Docs
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
15 May 2012, 9:39 am
The number of federal Pradaxa lawsuits filed against Boehringer Ingelheim Pharmaceuticals has risen to 18 after 8 more lawsuits were filed. [read post]
13 May 2010, 4:44 pm by mcarzima@imediainc.com
  The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
26 Oct 2021, 12:41 am by Florence Plisner (Bristows)
On 8 October 2021, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in an action brought by Royalty Pharma Collection Trust (“Royalty Pharma”) for approximately €23 million in royalty payments from Boehringer Ingelheim GmbH (“Boehringer”) (Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH [2021] EWHC 2692 (Pat)). [read post]
26 Oct 2012, 4:31 am by Ben Vernia
According to DOJ’s press release: Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD) drugs Atrovent and Combivent, and the hypertension drug Micardis, the Justice Department announced today. [read post]
27 Feb 2007, 9:32 pm
  Boehringer Ingelheim is Astellas Pharma's U.S. marketing partner. [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
7 Nov 2017, 11:36 am by Tom Lamb
The most recent medical journal article we have seen concerning this drug safety issue singles out the SGLT2 inhibitors which contain the active empagliflozin, which are listed below: Jardiance (empagliflozin) — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2014 Glyxambi (empagliflozin and linagliptin) — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2015 Synjardy (empagliflozin and metformin hydrochloride)… [read post]
1 Feb 2007, 4:56 pm
The government announced that it was joining a qui tam lawsuit under the False Claims Act against the company Boehringer Ingelheim Roxane, Inc. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
31 Mar 2014, 7:58 am by Robert Kraft
Reuters reported than over 2,000 lawsuits in the US have been filed against German pharmaceutical firm Boehringer Ingelheim over its blockbuster blood thinning medicine Pradaxa (dabigatran etexilate). [read post]
20 Mar 2012, 3:19 am by Cal Warriner
Boehringer Ingelheim, a German pharmaceutical company beat all competitors to the market with its new wonder drug Pradaxa. [read post]